AstraZeneca contacted Gilead over potential megamerger: Bloomberg News
Published
Britain's AstraZeneca has approached U.S. rival Gilead Sciences about a possible merger to form one the world's largest drug companies, Bloomberg News reported on Sunday, citing people familiar with the matter.
Full Article